Heron Therapeutics

Heron Therapeutics Inc (NASDAQ: HRTX) announced on Monday that the U.S. Food and Drug Administration (FDA) has not taken any action on its New Drug Application (NDA) for SUSTOL. The FDA informed Heron Therapeutics that it has not yet concluded a review of the NDA despite a January 17, 2016,...